Top Markets
Coin of the day
Renalytix Plc Renalytix Plc

Renalytix Plc

RNLX
Pozycja w akcjach #33997
Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc... Renalytix Plc, established in New York in 2018 and known as Renalytix AI plc until its name change in June 2021, focuses on creating artificial intelligence-driven in vitro diagnostic tools for kidney ailments. Its primary product, KidneyIntelX, is an advanced diagnostic system that utilizes an AI-powered algorithm. This algorithm integrates multiple data sources, including scientifically validated blood markers, genetic predispositions, and individual patient information from electronic health records, to produce a distinct risk score for kidney disease. The company's technology is applied in various areas: identifying and predicting the course of kidney disease, informing clinical treatment, selecting patients for pharmaceutical trials, and discovering new therapeutic targets. Renalytix has formed several strategic collaborations, such as licensing agreements with Mount Sinai Health System for AI-assisted kidney disease diagnosis, with Joslin Diabetes Center, Inc. for developing biomarker-based kidney disease prediction products, and with Kantaro Biosciences LLC for laboratory tests to detect SARS-CoV-2 antibodies. Furthermore, it has partnered with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to introduce an innovative clinical care model aimed at improving kidney health outcomes and preventing disease advancement and failure in vulnerable populations.
Cena akcji
$0.1502
Ostatnia synchronizacja: 2024-11-04
Kapitalizacja rynkowa
$6.43M
Zmiana (1 dzień)
-5.45%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Renalytix Plc (RNLX)

Kategoria

EPS dla Renalytix Plc (RNLX)
EPS na dzień September 2024 TTM: $-0.52
Według najnowszych raportów finansowych i ceny akcji firmy Renalytix Plc, obecny EPS (TTM) wynosi $-0.52. Na koniec roku 2023 firma miała EPS w wysokości $-1.10, spadek w porównaniu do do EPS z roku 2022, który wynosił $-1.24.
Historia EPS dla Renalytix Plc od 2018 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
2026 (TTM) $-0.52 -16.13%
2024 $-0.62 -43.64%
2023 $-1.10 -11.29%
2022 $-1.24 26.53%
2021 $-0.98 188.24%
2020 $-0.34 -82.83%
2019 $-1.98 3,200.00%
2018 $-0.06 0.00%
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
$3.48 -769.23%
US
$1.50 -388.62%
AU
$1.43 -375.00%
US
$-1.43 175.00%
US
- -
US